Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus

Background: Patients with diabetes mellitus (DM) are known to be at high-risk for both ischemic and bleeding complications post-percutaneous coronary intervention (PCI). The ischemic benefit vs. bleeding risk associated with extended dual antiplatelet therapy (DAPT) in high-risk “TWILIGHT-like” pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao-Yu, Cai, Zhong-Xing, Yin, Dong, Song, Wei-Hua, Feng, Lei, Gao, Run-Lin, Yang, Yue-Jin, Dou, Ke-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728996/
https://www.ncbi.nlm.nih.gov/pubmed/33330647
http://dx.doi.org/10.3389/fcvm.2020.586491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728996/
https://www.ncbi.nlm.nih.gov/pubmed/33330647
http://dx.doi.org/10.3389/fcvm.2020.586491

Ejemplares similares